Page 255 - Ahead News Today

Intercontinental Exchange: ICE Provides Update on ICE Murban Futures Ahead of Launch of ICE Futures Abu Dhabi on March 29, 2021 IFAD receives regulatory approval from the Monetary Authority of Singapore Intercontinental Exchange, Inc. (NYSE:ICE), a leading operator of global exchanges and clearing houses and provider of mortgage technology, data and listings services, today provides an update on ICE Futures Abu Dhabi (IFAD). ICE plans to launch IFAD and trading in ICE Murban Crude Oil Futures ...

The America's Cup Challengers face off in the opening press conference.

All you need to know as the three America's Cup challengers face off in the Prada Cup.

Mercury dropped to six degrees Celsius in Karachi on early Monday morning under the influence of a cold wave that has gripped the entire country these days, said the Pakistan Meteorological...

Whanganui weather: Warm and dry days ahead 12 Jan, 2021 04:00 AM 2 minutes to read Whanganui temperatures are expected to hover around 25 degrees all the way up to Sunday. Photo / Bevan Conley Whanganui temperatures are expected to hover around 25 degrees all the way up to Sunday. Photo / Bevan Conley Whanganui is set for some of the hottest days of the new year so far, as a high-pressure system continues to make its way across the country, bringing calm days and high temperatures. According to...

Federal law enforcement officials have advised police agencies to increase their security posture at statehouses around the country

And bright-line test will form part of the picture in helping cool the housing market.

Limitless Venture Group, Inc.: Limitless Venture Issues Letter to Shareholders on the Road Ahead TULSA, OK / ACCESSWIRE / January 12, 2021 / (OTCMKTS:LVGI) Limitless Venture Group, Inc. ("Limitless", "LVGI", or the "Company"), a publicly-traded holding company that provides its shareholders with access to investment opportunities in small and medium-sized businesses uniquely positioned for rapid growth, issues the following Letter to Shareholders on behalf of the CEO: Dear Valued Shareholder, A...

BioInvent streamlines agreement on anti-FcγRllB antibody, BI-1206, ahead of Phase I/II data Lund, Sweden - January 11, 2021- BioInvent International AB today... | January 16, 2021

BioInvent streamlines agreement on anti-FcyRllB antibody, BI-1206, ahead of Phase I/II data LUND, Sweden, Jan. 11, 2021 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces it has restructured a clinical development agreement with Cancer Research UK (CRUK), the worlds leading cancer charity, for its unique anti-FcyRIIB antibody, BI-1206. In exchange for a one-time payment, the revised deal simplifies and reduces BioInvents obligations to CRUK, w...